Abstract
Osteosclerotic metaphyseal dysplasia (OSMD) is a rare skeletal dysplasia characterized by osteosclerotic metaphyses with osteopenic diaphyses of the long tubular bones. Our previous study identified a homozygous elongation mutation in leucine-rich repeat kinase 1 gene (LRRK1) in a patient with OSMD and showed that Lrrk1 knockout mice exhibited phenotypic similarity with OSMD. Here we report a second LRRK1 mutation in Indian sibs with OSMD. They had homozygous mutation (c.5971_5972insG) that produces an elongated mutant protein (p.A1991Gfs*31) similar to the first case. The sibs had normal stature, normal intelligence and recurrent fractures. The common radiographic feature was asymmetric and variable sclerosis of vertebral end plates, pelvic margin and metaphyses of tubular bones. One of the sibs had facial dysmorphisms, dentine abnormalities and acro-osteolysis. A comparison between the three OSMD cases with LRRK1 mutations with different ages suggested that the sclerotic lesions resolved with age. Our findings further support that LRRK1 would cause a subset of OSMD cases.
Similar content being viewed by others
Introduction
Osteosclerotic metaphyseal dysplasia (OSMD; MIM 615198) is a rare sclerosing bone disorder characterized clinically by developmental delay, hypotonia and late-onset spastic paraplegia.1, 2 The radiographic manifestations consist of osteosclerosis localized predominantly to the metaphyses of the long tubular bones, which also have osteopenic diaphyses.2, 3, 4, 5 The osteosclerotic changes also occur to a lesser degree in metaphyseal equivalents of other bones, including ends of ribs and clavicles, iliac crests, ischio-pubic synchondroses and vertebral end plates. The skull is reported to be spared. In some cases, aberrant results of clinical biochemistry test have been reported, including elevated levels of serum alkaline phosphatase, aspartate aminotransferase and creatine kinase.2, 3, 4, 5
OSMD is considered to be an autosomal recessive disorder.2 Our previous study identified a homozygous frame-shift mutation in leucine-rich repeat kinase 1 gene (LRRK1, MIM 610986) in one OSMD patient from consanguineous parents.6 The study also showed that close phenotypic similarity of Lrrk1 knockout mice with OSMD, suggesting that loss of LRRK1 function would result in OSMD.6, 7 As no LRRK1 mutations were found in other two OSMD patients examined in the study, OSMD was presumed to be a genetically heterogeneous condition.6 The idea is supported by the difference of phenotypes between the OSMD patients with and without LRRK1 mutations.
In this study, by conducting whole-exome sequencing in sib cases of OSMD, we discovered a novel homozygous LRRK1 mutation.
Materials and methods
Patients
We identified an Indian family with OSMD (Supplementary Figure S1). The non-consanguineous healthy couple had two affected children, a healthy daughter and three abortions.
Patient 1
The proband (II-5 in Supplementary Figure S1) was a 14-year-old boy who suffered from recurrent fractures by trivial trauma. He was born at term by normal vaginal delivery. He was noticed to have abnormal bones when he was investigated for vomiting at the age of 1 year (Figures 1a–d). He had eight fractures since 2 years of age. A radiograph at age 3 years showed marked resolution of the sclerotic lesions of hands and forearms (Figure 1e). He had valgus deformity of the knee, which was surgically repaired bilaterally by medial hemi-epiphysiodesis of the femur and tibia at age 14 years.
On examination at age 12 years, his height and weight were 147 cm (−1 SD) and 52 kg (0.7 SD), respectively. Occipito-frontal circumference was 53 cm (2 SD). He had mild facial dysmorphism, including large ears with upturned ear lobules, hypoplastic alae nasi, enamel hypoplasia and crowding of teeth (Figures 2a–c). He had mild joint laxity and bilateral pes planus. Fingers were swollen bilaterally with shortened finger tips of index fingers (Figure 2d). Hepatomegaly (3 cm below right costal margin) was noted. Complete blood count, peripheral smear and serum calcium, phosphorous and alkaline phosphatase were within normal limits.
Skeletal survey at age 12 years (Figure 3) showed osteosclerosis of spine (rugger-jersey spine), marginal sclerosis of pelvis, metaphyseal sclerosis of the long and short tubular bones with under-modeling. Acro-osteolysis was noted in both index fingers and the right middle finger. Variable severity of osteosclerosis of metacarpals, metatarsals and phalanges were observed. The lesions showed significant asymmetry, particularly at lower ends of femur and metatarsal bones.
Patient 2
The elder sister of the proband (II-2 in Supplementary Figure S1) also had recurrent fractures (the left olecranon at age 13 years, the proximal phalanx of the left little finger at 15 years, lateral condyle of the right tibia and head of fibula at 20 years and the left femur shaft at 25 years). She had been told by the surgeons that her bones could not be drilled with ease and the narrow medullary canal did not accommodate a regular intramedullary rod.
She was evaluated at 25 years of age. She was 158 cm tall (−0.6 SD), weighed 65 kg (0.5 SD) and had a head circumference of 54 cm (2 SD). Her cognition was normal. She did not have facial dysmorphism, joint laxity and swollen finger tips.
Radiographs showed variable degree of sclerosis of end plates of the vertebral bodies, mild marginal sclerosis of iliac wing, well remodeled proximal femora with dense cortex, and under-modeling of radius, ulna, metacarpals and phalanges (Figure 4). Her skeletal lesions were far milder than those in the proband.
Whole-exome sequencing and variant calling
The study protocol was approved by the ethical committee of RIKEN and participating institutions. Peripheral bloods were obtained from the family members after the informed consent. Genomic DNAs were extracted from peripheral bloods using QIAamp DNA Blood Midi Kit (Qiagen, Hilden, Germany) according to the standard protocol. DNAs concentrations were measured by using a Qubit V.2.0 Fluorometer (Life Technologies, Carlsbad, CA, USA). Whole-exome sequencing was performed as previously described.8, 9 Briefly, DNA (3 μg) was sheared with a S2 ultrasonicator (Covaris, Wobum, MA, USA) and processed by SureSelectXT Human All Exon V5 (Agilent Technologies, Santa Clara, CA, USA). Captured DNA was sequenced using HiSeq 2000 (Illumina, San Diego, CA, USA) with 101 bp pair-end reads with seven indices. Image analysis and base calling were completed using HCS, RTA and CASAVA software (Illumina). Reads were mapped to the reference human genome (hg19) by Novoalign-3.02.04. Aligned reads were processed by Picard to remove PCR duplicates. Variants were called by GATK v2.7-4 following GATK Best Practice Workflow v310 and annotated by ANNOVAR.11
PCR and sanger sequencing
Sanger sequencing was performed to confirm the mutation identified by the whole-exome sequencing. A fragment including the mutation was amplified by PCR using primers, 5′-AGTGGTRCATCTCAGCACAC-3′ and 5′-CTTCCCTGGGGCTGTAAAAT-3′, and was sequenced in both strands. Sanger sequencing was performed on a 3730 DNA analyzer (Life Technologies). Sequencher V.4.7 (Gene Codes) and Genetyx (Genetyx Inc.) were used for aligning sequencing chromatographs to reference sequences.
Evaluation of the mutation identified in LRRK1
The mutation was evaluated by five databases, dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/), 1000 genomes (http://www.1000genomes.org/), ExAC (http://exac.broadinstitute.org/), ESP6500 (http://evs.gs.washington.edu/EVS/) and Human Gene Mutation Database (https://portal.biobase-international.com/hgmd/pro/start.php). Homozygosity mapping was performed by using Homozygosity Mapper as previously described12 on whole-exome sequencing data.
Results and discussion
We carried out whole-exome sequencing in the proband, and harvested about 2.6 Gb sequences. The sequences were successfully mapped to all human RefSeq. At least 96% of all coding regions were covered in a depth of 10 reads (Supplementary Table S1). We identified a homozygous 1 bp insertion (c.5971_5972insG) in the last exon of LRRK1. The insertion was not deposited in any available databases, including dbSNP, 1000 genomes, Human Gene Mutation Database and ESP6500. Homozygosity mapping using the whole-exome sequencing data showed that LRRK1 is residing in a 1.8 Mb homozygous stretch of the patient genome (Supplementary Table S2). Mutations in known candidate genes of osteopetrosis were not identified in the dataset. By Sanger sequencing, we confirmed the homogenous mutation in both patients (Supplementary Figure S2).
LRRK1 was identified as an oncogene that promotes tumor formation in nude mice.13 The LRRK1 gene (NM_024652) consists of 34 exons, which encompass about 150 kb on chromosome 15q26.3. LRRK1 encodes 2 015 amino acids and has a multi-domain that contains ankyrin repeats, leucine-rich repeats, Ras of complex proteins, C-terminal of Roc and serine threonine kinase domain, as well as seven tryptophan-aspartic acid dipeptide (WD) 40 domains at the C-terminus (Supplementary Figure S3).14, 15, 16 The 1 bp insertion (c.5971_5972insG) is located after the WD40 domain in the last exon of LRRK1. The mutation is predicted to result in a frame-shift and produce an elongated protein (p.A1991Gfs*31) without nonsense-mediated mRNA decay. The position of the mutation is very similar to another LRRK1 elongation mutation previously identified by us in one patient with OSMD (Supplementary Figure S3).6
OSMD is a very rare disorder, and only seven patients in six families have been reported.2, 3, 4, 5, 6 We previously identified a homozygous mutation in LRRK1 in one OSMD patient from consanguineous parents.6 The mutation is a 7 bp deletion (c.5938_5944del7) within the last exon and is predicted to produce an elongated mutant protein (p.E1980Afs*66) (Supplementary Figure S3). Overexpression of the elongated mutant protein cannot rescue the bone resorption defect of Lrrk1-deficient osteoclasts, suggesting its hypomorphic effect. This is consistent with the phenotypic similarity of Lrrk1 knockout mice with the OSMD patient carrying the elongation mutation.6 Interestingly, the novel mutation (c.5971_5972insG) identified in two siblings in this study is also located in the last exon and is predicted to produce a similar elongated mutant protein (p.A1991Gfs*31).
The phenotype of OSMD with LRRK1 mutations has not been clarified because only one infant case complicated by Duchenne muscular dystrophy has been identified6. The current study could add two cases with different ranges of the age until after skeletal maturity. The three cases with LRRK1 mutations did not have intellectual disability and epilepsy that were previously reported in OSMD2 (Table 1). The first case with LRRK1 mutation reported by Iida et al.6 presented with failure to thrive, hypotonia and a delay in psychomotor development, but these findings were absent in our sibs. The features were probably due to the complication of Duchenne muscular dystrophy in the first case. In contrast, recurrent fractures characteristic to our sib cases were not found in the first case. This is probably because of age. The first case was under 2-year old and the fractures in the sibs started after infancy. Only the proband of the sib cases had facial dysmorphysm, which have not been described in other OSMD patients. Also, dental abnormalities were found only in the proband, whereas this abnormality is common in osteopetrosis. Radiographic features of the three cases shared similarities: lack of platyspondyly, osteosclerosis of spine, pelvic margins and metaphyses of the long and short tubular bones with under-modeling (Table 1); however, the severity and distribution of osteosclerosis are variable. The comparison of the three cases of different ages indicated that the sclerotic change and under-modeling resolve with advancing age, which may make clinical diagnosis difficult. Further studies are necessary to clarify the phenotype of OSMD with LRRK1 mutation.
References
Bonafe, L., Cormier-Daire, V., Hall, C., Lachman, R., Mortier, G., Mundlos, S. et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am. J. Med. Genet. A 167, 2869–2892 (2015).
Nishimura, G. & Kozlowski, K. Osteosclerotic metaphyseal dysplasia. Pediatr. Radiol. 23, 450–452 (1993).
Kasapkara, C. S., Küçükçongar, A., Boyunağa, O., Bedir, T., Oncü, F., Hasanoğlu, A. et al. An extremely rare case: osteosclerotic metaphyseal dysplasia. Genet. Couns. 24, 69–74 (2013).
Mennel, E. A. & John, S. D. Osteosclerotic metaphyseal dysplasia: a skeletal dysplasia that may mimic lead poisoning in a child with hypotonia and seizures. Pediatr. Radiol. 33, 11–14 (2003).
Zheng, H., Cai, J., Wang, L. & He, X. Osteosclerotic metaphyseal dysplasia with extensive interstitial pulmonary lesions: a case report and literature review. Skeletal Radiol. 44, 1529–1533 (2015).
Iida, A., Xing, W., Docx, M. K. F., Nakashima, T., Wang, Z., Kimizuka, M. et al. Identification of biallelic LRRK1 mutations in osteosclerotic metaphyseal dysplasia and evidence for locus heterogeneity. J. Med. Genet. 53, 568–574 (2016).
Xing, W., Liu, J., Cheng, S., Vogel, P., Mohan, S. & Brommage, R. Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis. J. Bone Miner. Res. 28, 1962–1974 (2013).
Nakajima, M., Mizumoto, S., Miyake, N., Kogawa, R., Iida, A., Ito, H. et al. Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders. Am. J. Hum. Genet. 92, 927–934 (2013).
Nakajima, J., Okamoto, N., Tohyama, J., Kato, M., Arai, H., Funahashi, O. et al. De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy. Clin. Genet. 87, 356–361 (2015).
Mckenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A. et al. The Genome Analysis Toolkit : a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
Wang, K., Li, M. & Hakonarson, H. ANNOVAR : functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, 1–7 (2010).
Miyatake, S., Tada, H., Moriya, S., Takanashi, J., Hirano, Y., Hayashi, M. et al. Atypical giant axonal neuropathy arising from a homozygous mutation by uniparental isodisomy. Clin. Genet. 87, 395–397 (2015).
Korr, D., Toschi, L., Donner, P., Pohlenz, H.-D., Kreft, B. & Weiss, B. LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell. Signal. 18, 910–920 (2006).
Civiero, L., Bubacco, L., Paisán-RuÃz, C., Jain, S., Evans, E. W., Gilks, W. P. et al. Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions? Biochem. Soc. Trans. 40, 1095–1101 (2012).
Bosgraaf, L. & Van Haastert, P. J. M. Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta. 1643, 5–10 (2003).
MarÃn, I. The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol. Biol. Evol. 23, 2423–2433 (2006).
Acknowledgements
We thank the patients and their families for their help to the study. We also thank N. Atsumi for checking English. This study is supported by research grants from Japan Agency For Medical Research and Development (AMED) (contract No. 14525125) and from The Department of Science and Technology, Government of India (‘Application of autozygosity mapping and exome sequencing to identify genetic basis of disorders of skeletal development’: SB/SO/HS/005/2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Journal of Human Genetics website
Rights and permissions
About this article
Cite this article
Guo, L., Girisha, K., Iida, A. et al. Identification of a novel LRRK1 mutation in a family with osteosclerotic metaphyseal dysplasia. J Hum Genet 62, 437–441 (2017). https://doi.org/10.1038/jhg.2016.136
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhg.2016.136
This article is cited by
-
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Nature Structural & Molecular Biology (2022)
-
Recapitulating the human segmentation clock with pluripotent stem cells
Nature (2020)
-
Whole exome sequencing in ADHD trios from single and multi-incident families implicates new candidate genes and highlights polygenic transmission
European Journal of Human Genetics (2020)
-
Dysosteosclerosis is also caused by TNFRSF11A mutation
Journal of Human Genetics (2018)
-
Further expansion of the mutational spectrum of spondylo-meta-epiphyseal dysplasia with abnormal calcification
Journal of Human Genetics (2018)